Starting April 21, you’ll be asked to log in or sign up for a free account after viewing 10 content pages each month.
Don’t worry—creating an account is quick and easy, and it comes with added benefits! Once logged in, you’ll not only continue accessing the content you already enjoy, but you’ll also unlock exclusive features like interactive donut plots for variant protein effects and variant impacts across the gene.
Stay tuned for these updates, and thank you for being part of our community!
Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | ISB 1442 |
Trade Name | |
Synonyms | ISB-1442|ISB1442 |
Drug Descriptions |
ISB 1442 is a bispecific antibody that targets CD38 and CD47, potentially leading to enhanced tumor cell killing and inhibition of tumor growth (Cancer Res 2022;82(12_Suppl):Abstract nr 2903). |
DrugClasses | CD38 Antibody 21 CD47 Antibody 31 |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
ISB 1442 | ISB 1442 | 0 | 1 |